Correlation Between Dongbu Insurance and Pharmicell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dongbu Insurance and Pharmicell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dongbu Insurance and Pharmicell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dongbu Insurance Co and Pharmicell, you can compare the effects of market volatilities on Dongbu Insurance and Pharmicell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dongbu Insurance with a short position of Pharmicell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dongbu Insurance and Pharmicell.

Diversification Opportunities for Dongbu Insurance and Pharmicell

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dongbu and Pharmicell is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Dongbu Insurance Co and Pharmicell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmicell and Dongbu Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dongbu Insurance Co are associated (or correlated) with Pharmicell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmicell has no effect on the direction of Dongbu Insurance i.e., Dongbu Insurance and Pharmicell go up and down completely randomly.

Pair Corralation between Dongbu Insurance and Pharmicell

Assuming the 90 days trading horizon Dongbu Insurance Co is expected to generate 0.52 times more return on investment than Pharmicell. However, Dongbu Insurance Co is 1.94 times less risky than Pharmicell. It trades about -0.06 of its potential returns per unit of risk. Pharmicell is currently generating about -0.07 per unit of risk. If you would invest  10,370,000  in Dongbu Insurance Co on November 7, 2024 and sell it today you would lose (370,000) from holding Dongbu Insurance Co or give up 3.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dongbu Insurance Co  vs.  Pharmicell

 Performance 
       Timeline  
Dongbu Insurance 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dongbu Insurance Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Pharmicell 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmicell are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Pharmicell sustained solid returns over the last few months and may actually be approaching a breakup point.

Dongbu Insurance and Pharmicell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dongbu Insurance and Pharmicell

The main advantage of trading using opposite Dongbu Insurance and Pharmicell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dongbu Insurance position performs unexpectedly, Pharmicell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmicell will offset losses from the drop in Pharmicell's long position.
The idea behind Dongbu Insurance Co and Pharmicell pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world